Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.
| Revenue (Most Recent Fiscal Year) | $32.36B |
| Net Income (Most Recent Fiscal Year) | $3.68B |
| PE Ratio (Current Year Earnings Estimate) | 14.32 |
| PE Ratio (Trailing 12 Months) | 15.63 |
| PEG Ratio (Long Term Growth Estimate) | 1.97 |
| Price to Sales Ratio (Trailing 12 Months) | 3.22 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.16 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 11.59 |
| Pre-Tax Margin (Trailing 12 Months) | 15.73% |
| Net Margin (Trailing 12 Months) | 12.83% |
| Return on Equity (Trailing 12 Months) | 14.07% |
| Return on Assets (Trailing 12 Months) | 7.70% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.90 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.43 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.48 |
| Inventory Turnover (Trailing 12 Months) | 2.12 |
| Book Value per Share (Most Recent Fiscal Quarter) | $37.97 |
| Earnings per Share (Most Recent Fiscal Quarter) | $1.39 |
| Earnings per Share (Most Recent Fiscal Year) | $5.20 |
| Diluted Earnings per Share (Trailing 12 Months) | $3.29 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 1.28B |
| Free Float | 1.28B |
| Market Capitalization | $107.07B |
| Average Volume (Last 20 Days) | 5.90M |
| Beta (Past 60 Months) | 0.81 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.20% |
| Percentage Held By Institutions (Latest 13F Reports) | 82.06% |
| Annual Dividend (Based on Last Quarter) | $2.80 |
| Dividend Yield (Based on Last Quarter) | 3.35% |